The global vital sign monitoring devices market is experiencing significant growth, driven by the increasing prevalence of chronic diseases, technological advancements, and a growing emphasis on patient-centric care. These devices play a crucial role in monitoring essential health parameters, enabling timely medical interventions and improved patient outcomes.
The global vital sign monitoring devices market size was valued at USD 5.87 billion in 2024. It is expected to grow to USD 6.27 billion in 2025 and reach USD 10.47 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.6% over the forecast period.
Top Companies in the Market
- Masimo (U.S.)
- OMRON HEALTHCARE Co., Ltd. (Japan)
- Medtronic (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- GE Healthcare (U.S.)
- Contec Medical Systems Co. Ltd. (China)
- Nonin (U.S.)
- SunTech Medical, Inc. (U.S.)
Key Industry Developments
- April 2024: GE Healthcare received U.S. FDA approval for its Portrait VSM vital signs monitor, offering clinicians accurate and continuous monitoring of patient vital signs to support timely clinical decisions.
Market Drivers
- Rising Prevalence of Chronic Diseases: The increasing incidence of lifestyle-related chronic disorders, such as hypertension and diabetes, is propelling the demand for vital sign monitoring devices.
- Technological Advancements: Integration of artificial intelligence and machine learning in monitoring devices enhances accuracy and enables remote patient monitoring, driving market growth.
- Growing Geriatric Population: The aging population is more susceptible to chronic conditions, necessitating continuous monitoring and contributing to market expansion.
Market Restraints
- High Cost of Devices: The substantial cost associated with advanced monitoring devices may limit adoption, especially in emerging economies.